Aurobindo Pharma1713.40
-20.60 (-1.19%)

Aurobindo Pharma Share Price

1713.40-20.60 (-1.19%)
+53.09% past 1 Year

Corporate filings & documents

Announcements

Submission of newspaper publication.
just now
Intimation of investor Analyst meet scheduled on 24.09.2026.
13 hours ago
Intimation of investor Analyst meet scheduled on 24.09.2026.
13 hours ago
Submission of completion of US FDA inspection of Unit-II of Apitoria Pharma Private Limited a wholly owned subsidiary of the Company.
6 days ago
Submission of completion of US FDA inspection of Unit-II of Apitoria Pharma Private Limited a wholly owned subsidiary of the Company.
6 days ago
Submission of Press Release that is being issued in connection with receipt of US FDA final approval for Beclomethasone Dipropionate HFA Inhalation Aerosol 40 mcg and 80 mcg.
6 days ago
Submission of Press Release that is being issued in connection with receipt of US FDA final approval for Beclomethasone Dipropionate HFA Inhalation Aerosol 40 mcg and 80 mcg.
6 days ago
Intimation of subscription of 10 000 shares of USD 100 each of A1 Biochem USA Inc by A1 Biochem Labs (India) Private Limited a step down subsidiary of the Company.
1 week ago
Intimation of subscription of 10 000 shares of USD 100 each of A1 Biochem USA Inc by A1 Biochem Labs (India) Private Limited a step down subsidiary of the Company.
1 week ago
Intimation of completion of US FDA inspection of Unit-IV of Apitoria Pharma Private Limited a wholly owned subsidiary of the Company.
1 week ago
Intimation of completion of US FDA inspection of Unit-IV of Apitoria Pharma Private Limited a wholly owned subsidiary of the Company.
1 week ago
Intimation of investor / analyst meet scheduled on 22.09.2026.
1 week ago
Intimation of investor / analyst meet scheduled on 22.09.2026.
1 week ago
Intimation of investor / analyst meet scheduled on 21.09.2026.
1 week ago
Intimation of investor / analyst meet scheduled on 21.09.2026.
1 week ago
Intimation of investor / analyst meet scheduled on 17.09.2026.
1 week ago
Intimation of investor / analyst meet scheduled on 17.09.2026.
1 week ago
Intimation of investor / analyst meet scheduled on 18.09.2026.
1 week ago
Intimation of investor / analyst meet scheduled on 18.09.2026.
1 week ago
Intimation of Investor / analyst meet scheduled on 17.09.2026.
1 week ago
Intimation of Investor / analyst meet scheduled on 17.09.2026.
1 week ago
Submission of notice published in newspapers.
2 weeks ago
Submission of notice published in newspapers.
2 weeks ago
Intimation of incorporation of a new wholly owned subsidiary by the name of Ávogent Lifesciences Private Limited by Apitoria Pharma Private Limited a wholly owned subsidiary of the Company.
2 weeks ago
Intimation of incorporation of a new wholly owned subsidiary by the name of Ávogent Lifesciences Private Limited by Apitoria Pharma Private Limited a wholly owned subsidiary of the Company.
2 weeks ago
Submission of Press Release.
3 weeks ago
Submission of Press Release.
3 weeks ago
Intimation of completion of US FDA inspection at Unit-VI of Apitoria Pharma Private Limited a wholly owned subsidiary of the Company.
3 weeks ago
Intimation of completion of US FDA inspection at Unit-VI of Apitoria Pharma Private Limited a wholly owned subsidiary of the Company.
3 weeks ago
Submission of Voting Results and Scrutinizers Report of 39th AGM of the Company held on August 27 2026.
3 weeks ago
Submission of Voting Results and Scrutinizers Report of 39th AGM of the Company held on August 27 2026.
3 weeks ago
Submission of proceedings of 39th Annual General Meeting of the Company held on 27th August 2026.
3 weeks ago
Submission of proceedings of 39th Annual General Meeting of the Company held on 27th August 2026.
3 weeks ago
Intimation of Participation in Investor/ Analyst meet held on September 1-2 2026 in Hong Kong
3 weeks ago
Intimation of Participation in Investor/ Analyst meet held on September 1-2 2026 in Hong Kong
3 weeks ago
Intimation of Investor/ Analyst meet scheduled on September 1 2026.
3 weeks ago
Intimation of Investor/ Analyst meet scheduled on September 1 2026.
3 weeks ago
Intimation of completion of US FDA inspection at Lannett Company LLC. a wholly owned subsidiary of Aurobindo Pharma USA Inc.
4 weeks ago
Intimation of completion of US FDA inspection at Lannett Company LLC. a wholly owned subsidiary of Aurobindo Pharma USA Inc.
4 weeks ago
Intimation of completion of US FDA inspection at Auro Peptides Limited a subsidiary of the Company.
1 month ago
Intimation of completion of US FDA inspection at Auro Peptides Limited a subsidiary of the Company.
1 month ago
Intimation of classification of US FDA inspection at Raleigh Plant North Carolina owned by Aurolife LLF a wholly owned step down subsidiary of the Company as Voluntary Actioin Indicated (VAI).
1 month ago
Intimation of classification of US FDA inspection at Raleigh Plant North Carolina owned by Aurolife LLF a wholly owned step down subsidiary of the Company as Voluntary Actioin Indicated (VAI).
1 month ago
Intimation of participation of officials of the Company in investors / analysts meet to be held on August 19 2026
1 month ago
Intimation of participation of officials of the Company in investors / analysts meet to be held on August 19 2026
1 month ago
Intimation of receipt of warning letter from US FDA by Unit 1 of Eugia Pharma Specialities Limited a wholly owned subsidiary of the Company.
1 month ago
Intimation of receipt of warning letter from US FDA by Unit 1 of Eugia Pharma Specialities Limited a wholly owned subsidiary of the Company.
1 month ago
Submission of transcript of the earning call on the unaudited financial results for the quarter ended June 30 2026.
1 month ago
Submission of transcript of the earning call on the unaudited financial results for the quarter ended June 30 2026.
1 month ago
Intimation of incorporation of a new wholly owned subsidiary.
1 month ago

Concalls & investor presentations

Aug 2026
ConcallPresentation
Aug 2026
May 2026
ConcallPresentation
May 2026
Feb 2026
ConcallPresentation
Feb 2026
Nov 2025
ConcallPresentation
Aug 2025
ConcallPresentation
Aug 2025
May 2025
Feb 2025
ConcallPresentation
Feb 2025
Nov 2024
ConcallPresentation
Nov 2024
Aug 2024
ConcallPresentation
Aug 2024
May 2024
ConcallPresentation
May 2024
Feb 2024
ConcallPresentation
Feb 2024
Nov 2023
ConcallPresentation
Nov 2023
Aug 2023
ConcallPresentation
Aug 2023
May 2023
ConcallPresentation
May 2023
Feb 2023
ConcallPresentation
Feb 2023
Nov 2022
ConcallPresentation
Nov 2022
Aug 2022
ConcallPresentation
Aug 2022
May 2022
ConcallPresentation
May 2022
Feb 2022
ConcallPresentation
Feb 2022
Jan 2022
Nov 2021
ConcallPresentation
Nov 2021
Aug 2021
ConcallPresentation
Aug 2021
Feb 2021
ConcallPresentation
Feb 2021
Nov 2020
ConcallPresentation
Nov 2020

Aurobindo Pharma Ltd Share Price Today

The Aurobindo Pharma Ltd share price today is ₹1655.60. During the trading session, the Aurobindo Pharma Ltd share price opened at ₹1646.00 and recorded an intraday high of ₹1668.00 and a low of ₹1646.00. Last closing price was ₹1653.10. Over the past 52 weeks, the Aurobindo Pharma Ltd share price has ranged between ₹1035.40 and ₹1717.00. The current Aurobindo Pharma Ltd stock price reflects real-time market activity based on executed trades on the exchange.